Merck Kgaa (MKGAF) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Merck Kgaa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.076 gentlemen welcome to the Merck investor and analyst conference call on 00:00:05.076 -- 00:00:08.320 first quarter 2025 as 00:00:08.320 -- 00:00:13.366 a reminder all participants will be in a listen-only mode I am now 00:00:13.366 -- 00:00:18.591 handing over to Florian Schrader head of investor relations who will lead you through 00:00:18.591 -- 00:00:22.854 this conference please go ahead sir thank 00:00:23.296 -- 00:00:29.157 you so much Heidi and a very warm welcome to this Merck q125 results call 00:00:29.157 -- 00:00:33.441 My name is Florian Schreder. I'm the head of investor relations here at Merck. 00:00:33.441 -- 00:00:38.245 I'm delighted to be joined today by Belen Garrigio, our group CEO, as well as Helene 00:00:38.245 -- 00:00:41.108 von Röder, our group CFO. 00:00:41.108 -- 00:00:46.453 For the Q&A part of this call, we will also have Matthias Heinzel, CEO LifeScience, 00:00:46.453 -- 00:00:52.058 Jean-Charles Wirth, designated CEO LifeScience, Peter Günther, CEO Healthcare, 00:00:52.058 -- 00:00:57.544 Danny Barzohar, designated CEO Healthcare, as well as Kai Beckmann, CEO 00:00:57.544 -- 00:00:59.245 Electronics. 00:00:59.245 -- 00:01:03.069 In the first couple of minutes of this call, we would like to guide you through the key 00:01:03.069 -- 00:01:08.755 slides of the presentation. After that, we will be more than happy to take your questions. 00:01:08.755 -- 00:01:13.598 With this, I would now like to hand over to Belen to start. 00:01:13.800 -- 00:01:19.105 Thank you, Florian, and welcome everybody from my side to our Q1 00:01:19.105 -- 00:01:24.431 earnings call. I am now on slide number five of the presentation, 00:01:24.431 -- 00:01:26.498 starting with the highlights. 00:01:26.498 -- 00:01:30.703 First of a...